Secondary Adjuvant Treatment for Patients With Isolated Tumor Cells in Bone Marrow
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Docetaxel
Sponsor: Oslo University Hospital
Collaborators: University of Tromso|Helse Stavanger HF|Sorlandet Hospital HF|Sykehuset Innlandet HF|Ullevaal University Hospital|Sykehuset i Vestfold HF|Sykehuset Ostfold|Alesund Hospital